NCT02969577 is a NA clinical trial of Exercise Program in Prostate Cancer, sponsored by University of Kansas Medical Center.

Who is sponsoring NCT02969577?

NCT02969577 is sponsored by University of Kansas Medical Center.

What drugs are being tested in NCT02969577?

Interventions in NCT02969577: Exercise Program, Diet and Nutrition Coaching, Usual Care with Attention.

What condition does NCT02969577 study?

NCT02969577 studies Prostate Cancer.

Is NCT02969577 still recruiting?

NCT02969577 is currently completed. Last updated 17 February 2021.

Last reviewed 2021-02-17 · How we verify

NCT02969577

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Staying Strong and Healthy During Androgen Deprivation Therapy (ADT) for Men

Completed NA Last updated 17 February 2021

What this trial tests

NA trial testing Exercise Program in Prostate Cancer in 38 participants. Completed in 31 July 2020.

Timeline

7 March 2017

Primary endpoint
1 July 2020

31 July 2020

Quick facts

Lead sponsor	University of Kansas Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	38
Start date	7 March 2017
Primary completion	1 July 2020
Estimated completion	31 July 2020
Sites	2 locations across United States

Drugs / interventions tested

Exercise Program
Diet and Nutrition Coaching
Usual Care with Attention

Conditions studied

Prostate Cancer — all drugs for Prostate Cancer →

Sponsor

University of Kansas Medical Center

Who can join

21 and older, male only, with Prostate Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to learn if lifestyle changes and counseling along with standard medical care, compared to standard medical care alone, can prevent heart problems and diabetes in men who are receiving ADT for prostate cancer treatment.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Preventive Cardio-Oncology: The Time Has Come.
Brown SA. · · 2019 · cited 35× · PMID 31998754 · DOI 10.3389/fcvm.2019.00187
Androgen Deprivation and Sleep Disturbance: A Mixed Methods Pilot Study of Remote Assessment and Intervention.
Myers JS, Siengsukon C, Sherman J, Shen X, et al · · 2023 · cited 5× · PMID 35439217 · DOI 10.1097/ncc.0000000000001100
Staying Strong and Healthy During Androgen Deprivation Therapy.
Myers JS, Manson A, Billinger SA, Hamilton-Reeves J, et al · · 2024 · cited 4× · PMID 35984916 · DOI 10.1097/ncc.0000000000001151
An Exploratory Study of Cognitive Function and Central Adiposity in Men Receiving Androgen Deprivation Therapy for Prostate Cancer.
Myers JS, Manson A, Billinger SA, Parker W, et al · · 2022 · cited 2× · PMID 35191898 · DOI 10.1188/22.onf.142-150

Verify or expand the search:

Other trials of Exercise Program

Trials testing the same drug.

NCT07333417 — Effects of Rigid Taping in Acromioclavicular Joint Degeneration · NA · recruiting
NCT07414914 — Self-Myofascial Release Plus Exercise Versus Exercise Alone in Type 2 Diabetes · NA · recruiting
NCT07190768 — Effectiveness of Kinesiologic Taping and Dry Needling in the Treatment of Subacromial Pain Syndrome · NA · not yet recruiting
NCT07241728 — Bruxism and Diadinamic Current · NA · recruiting
NCT07409064 — Effects of Exercise on Lipids and Endothelial Function in Youth · NA · recruiting

Other recruiting trials for Prostate Cancer

Currently open trials in the same condition.

NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting
NCT07234981 — PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer · Phase 2 · recruiting
NCT07027124 — Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Ris · Phase 2 · recruiting
NCT07426094 — PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate · Phase 2, PHASE3 · recruiting

Other University of Kansas Medical Center trials

Trials by the same sponsor.

NCT06636214 — Adapting Changing Talk: Online (CHATO) to CHATO-Inclusive · NA · not yet recruiting
NCT07528963 — KanSurvive 2.0: Testing Enhanced Models of Cancer Survivorship Care for Rural Cancer Survivors in Primary Care Practice · NA · enrolling by invitation
NCT07463755 — Low-Fidelity Driving Simulator Training in Parkinson's Disease. · NA · not yet recruiting
NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
NCT07491510 — Improving Prenatal Care to Reduce Early Onset Preeclampsia in Low-Income · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02969577 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Kansas Medical Center
Last refreshed: 17 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02969577.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing